{"id":5638,"date":"2024-06-13T16:30:14","date_gmt":"2024-06-13T16:30:14","guid":{"rendered":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/?p=5638"},"modified":"2024-06-14T01:08:28","modified_gmt":"2024-06-14T01:08:28","slug":"meskis","status":"publish","type":"post","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/","title":{"rendered":"Mary Anne Meskis"},"content":{"rendered":"<p><img decoding=\"async\" class=\"lazyload alignnone size-full wp-image-5639\" src=\"http:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis.png\" data-orig-src=\"http:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27300%27%20height%3D%27300%27%20viewBox%3D%270%200%20300%20300%27%3E%3Crect%20width%3D%27300%27%20height%3D%27300%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis-66x66.png 66w, https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis-150x150.png 150w, https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis-200x200.png 200w, https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis.png 300w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son&#8217;s diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along with fostering patient community engagement and education. Currently, she resides in western North Carolina with her husband and the youngest of her three children, Elliot, who has Dravet syndrome.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son&#8217;s diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along<\/p>\n","protected":false},"author":6,"featured_media":5639,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-5638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-creative"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son&#039;s diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"mkavounis\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NINDS Genetic Strategies to Treat the Epilepsies -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies\" \/>\n\t\t<meta property=\"og:description\" content=\"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son&#039;s diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-06-13T16:30:14+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-06-14T01:08:28+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son&#039;s diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#blogposting\",\"name\":\"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies\",\"headline\":\"Mary Anne Meskis\",\"author\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/wp-content\\\/uploads\\\/sites\\\/91\\\/2024\\\/06\\\/Mary-Ann-Meskis.png\",\"width\":300,\"height\":300},\"datePublished\":\"2024-06-13T16:30:14+00:00\",\"dateModified\":\"2024-06-14T01:08:28+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#webpage\"},\"articleSection\":\"Creative\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/#listItem\",\"name\":\"Creative\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/#listItem\",\"position\":2,\"name\":\"Creative\",\"item\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#listItem\",\"name\":\"Mary Anne Meskis\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#listItem\",\"position\":3,\"name\":\"Mary Anne Meskis\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/#listItem\",\"name\":\"Creative\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#organization\",\"name\":\"Symposium for Promoting the Advancement of Research Knowledge in ME\\\/CFS (SPARKME)\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/\",\"name\":\"mkavounis\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78999b25f9750bfe24c485d98fc21efbd175a28006611d732e517a5d6e52275c?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"mkavounis\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#webpage\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/\",\"name\":\"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies\",\"description\":\"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son's diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/wp-content\\\/uploads\\\/sites\\\/91\\\/2024\\\/06\\\/Mary-Ann-Meskis.png\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#mainImage\",\"width\":300,\"height\":300},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/meskis\\\/#mainImage\"},\"datePublished\":\"2024-06-13T16:30:14+00:00\",\"dateModified\":\"2024-06-14T01:08:28+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#website\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/\",\"name\":\"Symposium for Promoting the Advancement of Research Knowledge in ME\\\/CFS (SPARKME)\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies","description":"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son's diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along","canonical_url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#blogposting","name":"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies","headline":"Mary Anne Meskis","author":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author"},"publisher":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis.png","width":300,"height":300},"datePublished":"2024-06-13T16:30:14+00:00","dateModified":"2024-06-14T01:08:28+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#webpage"},"isPartOf":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#webpage"},"articleSection":"Creative"},{"@type":"BreadcrumbList","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies#listItem","position":1,"name":"Home","item":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies","nextItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/#listItem","name":"Creative"}},{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/#listItem","position":2,"name":"Creative","item":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/","nextItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#listItem","name":"Mary Anne Meskis"},"previousItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#listItem","position":3,"name":"Mary Anne Meskis","previousItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/#listItem","name":"Creative"}}]},{"@type":"Organization","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#organization","name":"Symposium for Promoting the Advancement of Research Knowledge in ME\/CFS (SPARKME)","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/"},{"@type":"Person","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/","name":"mkavounis","image":{"@type":"ImageObject","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/78999b25f9750bfe24c485d98fc21efbd175a28006611d732e517a5d6e52275c?s=96&d=mm&r=g","width":96,"height":96,"caption":"mkavounis"}},{"@type":"WebPage","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#webpage","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/","name":"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies","description":"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son's diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#website"},"breadcrumb":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#breadcrumblist"},"author":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author"},"creator":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Mary-Ann-Meskis.png","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#mainImage","width":300,"height":300},"primaryImageOfPage":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/#mainImage"},"datePublished":"2024-06-13T16:30:14+00:00","dateModified":"2024-06-14T01:08:28+00:00"},{"@type":"WebSite","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#website","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/","name":"Symposium for Promoting the Advancement of Research Knowledge in ME\/CFS (SPARKME)","inLanguage":"en-US","publisher":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#organization"}}]},"og:locale":"en_US","og:site_name":"NINDS Genetic Strategies to Treat the Epilepsies -","og:type":"article","og:title":"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies","og:description":"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son's diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along","og:url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/","article:published_time":"2024-06-13T16:30:14+00:00","article:modified_time":"2024-06-14T01:08:28+00:00","twitter:card":"summary_large_image","twitter:title":"Mary Anne Meskis - NINDS Genetic Strategies to Treat the Epilepsies","twitter:description":"Mary Anne is a founding member and the Executive Director of the Dravet Syndrome Foundation (DSF). She is a passionate advocate for the Dravet syndrome and rare epilepsy communities. Since her son's diagnosis in 2004, she has actively participated in numerous working groups and industry advisory panels. Under her leadership, DSF has prioritized research, along"},"aioseo_meta_data":{"post_id":"5638","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2024-06-13 16:30:14","updated":"2025-07-23 20:34:15","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/\" title=\"Creative\">Creative<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tMary Anne Meskis\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies"},{"label":"Creative","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/"},{"label":"Mary Anne Meskis","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/meskis\/"}],"_links":{"self":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts\/5638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/comments?post=5638"}],"version-history":[{"count":1,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts\/5638\/revisions"}],"predecessor-version":[{"id":5640,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts\/5638\/revisions\/5640"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/media\/5639"}],"wp:attachment":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/media?parent=5638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/categories?post=5638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/tags?post=5638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}